Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
TVTXthis companyTravere Therapeutics, Inc.	$50.48	-68.23×	29.69×	6.95×	164.03×	-591.5%	97.9%	-12.8%	-5.2%	-22.2%	-13.9%	-0.6%	2.86×	10.61×	-5.85×	2.74×	0.0%	4	1.52	1	D+
MAZEMaze Therapeutics, Inc.	$34.25	-13.58×	5.02×	0×	-12.54×	-87.4%	0.0%	0.0%	0.0%	-36.9%	-37.7%	-6.3%	0.07×	1.29×	0×	15.5×	0.0%	3	11.54	2	C
MLYSMineralys Therapeutics, Inc.	$15.86	-15.85×	3.8×	0×	-14.76×	-83.7%	0.0%	0.0%	0.0%	-23.9%	-26.4%	-5.8%	0×	1.12×	0×	43.76×	0.0%	2	4.94	2	C
PROKProKidney Corp.	$1.15	-4.31×	-0.3×	335.98×	-3.99×	-22.6%	100.0%	-18477.8%	-7725.2%	6.8%	-53.9%	-45.1%	-0×	0.72×	-41,251.75×	9.13×	0.0%	1	-0.18	2	C
Peer median	—	-13.58×	3.8×	0×	-12.54×	-83.7%	0.0%	0.0%	0.0%	-23.9%	-37.7%	-6.3%	0×	1.12×	0×	15.5×	0.0%	2	4.94	2	—